News

The distinct patterns of perinatal intracranial hemorrhage (pIH), a feared FNAIT complication, were detailed in a recent study.

A recent report detailed the first case of FNAIT logged at a 180-year-old institution in India, complete with treatment methods and outcomes.

A Phase 2 clinical trial for an experimental treatment for FNAIT was recently approved by the European Medicines Agency.

A recent analysis described how the use of artificial intelligence (AI) is being integrated into infant health care and disease prediction.

A recent study showed donor characteristics can affect the quantity of platelets obtained for FNAIT platelet transfusions.

A recent study showed placenta-related biomarkers may play an important role in predicting FNAIT disease severity.

Researchers have successfully synthesized an antibody against the CD36 platelet antigen, which has potential therapeutic implications for FNAIT.

According to a recent press release, the Australian red cross is assessing the feasibility of non-invasive prenatal testing to detect certain antigens.

A recent literature review highlights the need for more research on blood donor characteristics and their impact on patient outcomes.

Results of a recent analysis showed that the risk for alloimmunization was highest among women in Caucasian populations.